Prognostic value of midregional Pro-A-Type natriuretic peptide and N-terminal Pro-B-Type natriuretic peptide in patients with stable coronary heart disease followed over 8 years

Ähnliche Einträge

• Evaluation of the clinical use of midregional pro-atrial natriuretic peptide (MR-proANP) in comparison to N-terminal pro-B-type natriuretic peptide (NT-proBNP) for risk stratification in patients with light-chain amyloidosis
  von: Kristen, Arnt, et al.
  Veröffentlicht: (2014)
• Prognostic value of plasma N-terminal pro-brain natriuretic peptide in patients with severe sepsis
  von: Brückmann, Martina, et al.
  Veröffentlicht: (2005)
• Serial measurements of N-terminal pro-brain natriuretic Peptide in patients with coronary heart disease
  Veröffentlicht: (2015)
• Prognostic implications of N-terminal pro-B-type natriuretic peptide and high-sensitivity cardiac troponin T in EMPEROR-Preserved
  von: Januzzi, James L., et al.
  Veröffentlicht: (2022)
• Cardiac troponin I but not n-terminal pro-b-type natriuretic peptide predicts outcomes in cardiogenic shock
  von: Schupp, Tobias, et al.
  Veröffentlicht: (2023)